ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
DeepHop.pdf (1.65 MB)

Deep Scaffold Hopping with Multi-modal Transformer Neural Networks

preprint
submitted on 27.09.2020 and posted on 28.09.2020 by Shuangjia Zheng, Zengrong Lei, Haitao Ai, Hongming Chen, Daiguo Deng, Yuedong Yang

Scaffold hopping, aiming to identify molecules with novel scaffolds but share a similar target biological activity toward known hit molecules, has always been a topic of interest in rational drug design. Computer-aided scaffold hopping would be a valuable tool but at present it suffers from limited search space and incomplete expert-defined rules and thus provides results of unsatisfactory quality. To addree the issue, we describe a fully data-driven model that learns to perform target-centric scaffold hopping tasks. Our deep multi-modal model, DeepHop, accepts a hit molecule and an interest target protein sequence as inputs and design bioisosteric molecular structures to the target compound. The model was trained on 50K experimental scaffold hopping pairs curated from the public bioactivity database, which spans 40 kinases commonly investigated by medicinal chemists. Extensive experiments demonstrated that DeepHop could design more than 70% molecules with improved bioactivity, high 3D similarity, while low 2D scaffold similarity to the template molecules. Our method achieves 2.2 times larger efficiency than state-of-the-art deep learning methods and 4.7 times than rule-based methods. Case studies have also shown the advantages and usefulness of DeepHop in practical scaffold hopping scenario.

Funding

This study has been supported by the National Natural Science Foundation of China (61772566, 62041209, and U1611261), Guangdong Key Field R&D Plan (2019B020228001 and 2018B010109006), Introducing Innovative and Entrepreneurial Teams (2016ZT06D211), Guangzhou S&T Research Plan (202007030010), the Guangdong Provincial Key Lab. of New Drug Design and Evaluation (Grant 2011A060901014).

History

Email Address of Submitting Author

zhengshj9@mail2.sysu.edu.cn

Institution

Sun Yat-sen University

Country

China

ORCID For Submitting Author

0000-0001-9747-4285

Declaration of Conflict of Interest

None

Version Notes

The first version

Exports